- Home
- THRM vs PRAX Comparison
THRM vs PRAX Comparison
Compare THRM & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRM
- PRAX
- Stock Information
- Founded
- THRM 1991
- PRAX 2015
- Country
- THRM United States
- PRAX United States
- Employees
- THRM N/A
- PRAX N/A
- Industry
- THRM Auto Parts:O.E.M.
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- THRM Consumer Discretionary
- PRAX Health Care
- Exchange
- THRM Nasdaq
- PRAX Nasdaq
- Market Cap
- THRM 997.7M
- PRAX 950.8M
- IPO Year
- THRM 1993
- PRAX 2020
- Fundamental
- Price
- THRM $35.49
- PRAX $42.00
- Analyst Decision
- THRM Buy
- PRAX Strong Buy
- Analyst Count
- THRM 3
- PRAX 9
- Target Price
- THRM $46.00
- PRAX $94.44
- AVG Volume (30 Days)
- THRM 203.5K
- PRAX 379.5K
- Earning Date
- THRM 10-29-2025
- PRAX 11-05-2025
- Dividend Yield
- THRM N/A
- PRAX N/A
- EPS Growth
- THRM N/A
- PRAX N/A
- EPS
- THRM 1.02
- PRAX N/A
- Revenue
- THRM $1,453,370,000.00
- PRAX $7,765,000.00
- Revenue This Year
- THRM $1.64
- PRAX N/A
- Revenue Next Year
- THRM $3.31
- PRAX $22.22
- P/E Ratio
- THRM $34.66
- PRAX N/A
- Revenue Growth
- THRM N/A
- PRAX 338.45
- 52 Week Low
- THRM $22.75
- PRAX $26.70
- 52 Week High
- THRM $51.00
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- THRM 52.29
- PRAX 43.28
- Support Level
- THRM $34.87
- PRAX $37.25
- Resistance Level
- THRM $36.12
- PRAX $40.69
- Average True Range (ATR)
- THRM 0.96
- PRAX 2.43
- MACD
- THRM -0.29
- PRAX -0.35
- Stochastic Oscillator
- THRM 35.39
- PRAX 40.97
About THRM Gentherm Inc
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.